The Medical Letter on Drugs and Therapeutics
May 12, 2003
|Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article.|
May 12, 2003 (Issue: 1156)Eplerenone (e pler' en one; Inspra - Pharmacia), an aldosterone receptor antagonist similar to spironolactone (Aldactone, and others), has been approved by the FDA, but not yet marketed, for treatment of hypertension. It has also been tried for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.